Free Trial

Tectonic Therapeutic Q2 2023 Earnings Report

Tectonic Therapeutic logo
$29.54 -1.29 (-4.18%)
As of 02/21/2025 04:00 PM Eastern

Tectonic Therapeutic EPS Results

Actual EPS
-$0.37
Consensus EPS
$1.35
Beat/Miss
Missed by -$1.72
One Year Ago EPS
N/A

Tectonic Therapeutic Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Tectonic Therapeutic Announcement Details

Quarter
Q2 2023
Time
N/A

Conference Call Resources

Tectonic Therapeutic Earnings Headlines

Tectonic Therapeutic to Participate in March Investor Conferences
Ex-CIA Advisor: Trump 2.0 Could “Send Gold to $10,000”
Experts forecast gold's price racing to $4,000… and an ex-CIA advisor predicts we'll see gold hit $10,000. Should you sit on the sideline while this is happening?
See More Tectonic Therapeutic Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Tectonic Therapeutic? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Tectonic Therapeutic and other key companies, straight to your email.

About Tectonic Therapeutic

Tectonic Therapeutic (NASDAQ:TECX), Inc. engages in discovery and development of therapeutic proteins & antibodies. The company was founded by Timothy A. Springer and Andrew Kruse in 2019 and is headquartered in Watertown, MA.

View Tectonic Therapeutic Profile

More Earnings Resources from MarketBeat